Type(s) of Cancer
Lymphoma
Lymphoma
Study Phase
Phase 2
Phase 2
Study Completion Date
October 2008
October 2008
NCT00301821Uploaded 09-11-2019
Access via NCI by Request
PDS UID - nci-data-372
A Phase II Study of Epratuzumab, Rituximab (ER)-CHOP for Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
Files: NCT00301821-D2



Data DictionaryNCT00301821-D2-Data-Dictionary_0.pdf

DATANCT00301821-D2-Dataset_0.csv

OTHERREADME.pdf
Files: NCT00301821-D1



Data DictionaryNCT00301821-D1-Data-Dictionary_0.pdf

DATANCT00301821-D1-Dataset.csv

OTHERREADME.pdf